Decreased short-term production of tumor necrosis factor-α and lnterleukin1β in human immunodeficiency virus-seropositive subjects

Journal of Infectious Diseases

Volumn 175, Issue 6, 1997, Pages 1507-1510

  Ullum, Henrik ^a   Victor, Jette ^a   Katzenstein, Terese L ^b   Gerstoft, Jan ^b   Gotzsche, Peter C ^b   Bendtzen, Klaus ^b   Skinhoj, Peter ^b   Pedersen, Bente Klarlund ^b  

^a Rigshospitalet   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL; SUPPRESSOR CELL;

EID: 0030911265     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/516488     Document Type: Article

References (14)

1. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor-α and interleukin l stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κß. Proc Natl Acad Sci USA 1989;86:2336-40.
2. Fong Y, Moldawer LL, Marano M, et al. Cachectin/TNF or IL-1 α induces cachexia with redistribution of body proteins. Am J Physiol 1989;256: R659-65.
3. Poli G, Fauci AS. Role of cytokines in the pathogenesis of human immunodeficiency virus infection. In: Aggarwal BB, Puri RK. Human cytokines and their role in health and human disease. Cambridge, MA: Blackwell Scientific, 1995:421-50.
4. Matsuyama T, Kobayashi N, Yamamoto N. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 1991;5:1405-17.
5. Jones PD, Shelley L, Wakefield D. Tumor necrosis factor-α in advanced HIV infection in the absence of AIDS-related secondary infections. J Acquir Immune Defic Syndr 1992;5:1266-71.
6. Ullum H, Gotzsche PC, Victor J, Dickmeiss E, Skinhoj P, Pedersen BK. Defective natural immunity - an early manifestation of human immunodeficiency virus infection. J Exp Med 1995;182:789-800.
7. Fomsgaard A, Worsaae H, Bendtzen K. Detection of tumour necrosis factor from lipopolysaccharide-stimulated human mononuclear cells by enzyme-linked immunosorbent assay and cytotoxicity bioassay. Scand J Immunol 1988;27:143-7.
8. Katzenstein T, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 1996;10:167-73.
9. Philip R, Epstein LB. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1. Nature 1986;323:86-9.
10. Vyakarnam A, Matear P, Meager A, et al. Altered production of tumour necrosis factors-α and -ß and interferon-γ by HIV-infected individuals. Clin Exp Immunol 1991;84:109-15.
11. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993;9:317-43.
12. Dinarello CA. Interleukin-l and interleukin-l antagonism. Blood 1991; 77:1627-52.
13. Dinarello CA, Cannon JG, Wolff SM, et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986;163:1433-50.
14. Genis P, Jett M, Bemton EW, et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 1992;176:1703-18.